
Eli Lilly, Regeneron Lead Weight-Loss ETF THNR Higher
来源:ETF Trends发布于 2026-11-04
The Amplify Weight Loss Drug & Treatment ETF (THNR) returned 3.2% in October, according to Amplify ETFs. Eli Lilly and Co. (LLY) drove most of that gain, after reporting quarterly results that beat Wa...
相关标的:#THNR
本文内容来自外部来源,点击「继续访问」将跳转到原始发布站点。